ArticleCancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology2026
Accelerated Aging and Risk of Subsequent Neoplasms in Survivors of Childhood Cancer: A Report from the Childhood Cancer Survivor Study.
Article in Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
18 authors.
Funding
Abstract
backgroundSurvivors of childhood cancer face elevated risks for treatment-related late effects, including subsequent malignant neoplasms (SMN). In the general population, accelerated aging is associated with increased malignancy risk; however, this has not been evaluated in survivors.
methodsSurvivors enrolled in the Childhood Cancer Survivor Study with measures of physiologic frailty, Cumulative Illness Rating Scale for Geriatrics (CIRS-G), or deficit accumulation index (DAI) data were included. Associations between these measures of accelerated aging with SMNs, benign meningiomas, and nonmelanoma skin cancers (NMSC) were estimated with piecewise exponential models, adjusted for sociodemographic, treatment, and modifiable factors.
resultsPhysiologic frailty and CIRS-G were not associated with risk of SMNs, meningiomas, or NMSCs. A higher DAI was only associated with increased risk of benign meningioma but not SMNs or NMSCs.
conclusionsAccelerated aging measures were not consistently associated with SMN risk in survivors of childhood cancer. IMPACT: Our results confirm that established risk factors, especially treatment exposures, remain critical in the development of SMNs in survivors, reinforcing the importance of risk-adapted therapies and long-term surveillance in survivorship care.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.